This event has concluded.
Improving Decisions from Discovery to IND
Join the ChemPartner team this month in Sweden for an inspiring lunch seminar!
At the seminar, you’ll be presented with current approaches and technologies in drug discovery within oncology and neuroscience research. The program will bring together perspectives on how different preclinical strategies and model systems support drug development from early discovery through IND.
Key aspects of antibody–drug conjugate (ADC) development will be covered, including considerations related to efficacy, safety, and resistance. Approaches to improving targeting, stability, and overall therapeutic performance will be outlined, alongside examples from ongoing research programs.
The meeting will also address challenges in central nervous system (CNS) drug discovery, focusing on how different experimental models are used to study disease mechanisms and evaluate drug candidates. Particular attention will be given to the role of in vitro systems, organoid models, and in vivo studies in generating translationally relevant data.
Attendees will be provided with an overview of how combined methodologies and platforms support decision-making and progression in modern drug discovery.
Event: Seminar Series with ChemPartner
Date: Tuesday, May 19, 2026
Time: 11:30 AM – 1:30 PM GMT
Location: Blickagangen 6
Huddinge, Sweden
To see a list of the speakers and to register, visit the link below!
